Effective gene therapy in a mouse model of prion diseases
about
The glial response to intracerebrally delivered therapies for neurodegenerative disorders: is this a critical issue?Treatment of Prion Disease with Heterologous Prion ProteinsFeline immunodeficiency virus as a gene transfer vector in the rat nucleus tractus solitariiDominant prion mutants induce curing through pathways that promote chaperone-mediated disaggregation.Systemic delivery of siRNA down regulates brain prion protein and ameliorates neuropathology in prion disorder.Insights into prion biology: integrating a protein misfolding pathway with its cellular environment.A naturally occurring C-terminal fragment of the prion protein (PrP) delays disease and acts as a dominant-negative inhibitor of PrPSc formation.A Fluorescent Oligothiophene-Bis-Triazine ligand interacts with PrP fibrils and detects SDS-resistant oligomers in human prion diseases.Heterozygous inhibition in prion infection: the stone fence modelTherapeutic interventions ameliorating prion disease.Prion diseases and adult neurogenesis: how do prions counteract the brain's endogenous repair machinery?Potential approaches for heterologous prion protein treatment of prion diseases.Manganese chelation therapy extends survival in a mouse model of M1000 prion disease.A dominant-negative mutant inhibits multiple prion variants through a common mechanism.Low doses of bioherbicide favour prion aggregation and propagation in vivo.
P2860
Q27023715-62C1BA20-6347-49EE-B6E9-86749FA370B0Q27303161-C2285C8A-9923-4379-9DF9-CDE077E57ED2Q33778126-8ED0E745-DF1B-4E33-A3DA-E2211C9C52F9Q34859274-73A0B725-637F-429D-B64E-C84234543380Q35097571-91078FBC-E2AF-4652-8975-B8D0D70BFE84Q35194908-C95AA665-E866-4D00-826B-5075CE223665Q35626193-A3D0A1AB-1311-43FD-842B-93CADF9B66CBQ36503630-8DC691F7-0792-4066-82F3-59F133E0FDF3Q37178389-445AD53D-C7B7-4B1E-B70F-AD9CFBD44405Q37557690-7370E265-6257-4760-BE57-AA7B33109668Q38994651-54284706-5289-4BE5-BD8B-22C8EFEDB41DQ40883026-4B563E52-3625-4B06-8DBD-5CECE3E27F62Q43067894-EEE0780F-234C-4CB3-8C7A-BAE49115AC80Q46002678-6204433C-F4A2-4D6A-A5AA-AECA5F414BD7Q54971223-7268F5CA-29C0-4C76-827D-32DBB8F27D6B
P2860
Effective gene therapy in a mouse model of prion diseases
description
2008 nî lūn-bûn
@nan
2008 թուականին հրատարակուած գիտական յօդուած
@hyw
2008 թվականին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Effective gene therapy in a mouse model of prion diseases
@ast
Effective gene therapy in a mouse model of prion diseases
@en
Effective gene therapy in a mouse model of prion diseases
@nl
type
label
Effective gene therapy in a mouse model of prion diseases
@ast
Effective gene therapy in a mouse model of prion diseases
@en
Effective gene therapy in a mouse model of prion diseases
@nl
prefLabel
Effective gene therapy in a mouse model of prion diseases
@ast
Effective gene therapy in a mouse model of prion diseases
@en
Effective gene therapy in a mouse model of prion diseases
@nl
P2093
P2860
P1433
P1476
Effective gene therapy in a mouse model of prion diseases
@en
P2093
Chantal Mourton-Gilles
Françoise Ibos
Karine Toupet
Nadine Mestre-Francés
Pierre Corbeau
Valérie Compan
Véronique Perrier
P2860
P356
10.1371/JOURNAL.PONE.0002773
P407
P577
2008-01-01T00:00:00Z